Latest California Healthline Stories
States Begin Tapping Medicaid Dollars to Combat Gun Violence
The Biden administration is allowing states to use money from the insurance program for low-income and disabled residents to pay for gun violence prevention. California and six other states have approved such spending, with more expected to follow.
In Year 6, KFF Health News-NPR’s ‘Bill of the Month’ Helps Patients in a Changing System
In the sixth year of the KFF Health News-NPR’ “Bill of the Month” series, patients shared more than 750 tales of medical billing problems, and reporters analyzed more than $730,000 in charges — including more than $215,000 owed by 12 patients and their families.
KFF Health News' 'What the Health?': Democrats See Opportunity in GOP Threats to Repeal Health Law
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
Biden Wants States to Ensure Obamacare Plans Cover Enough Doctors and Hospitals
The regulatory proposal was announced Nov. 15 and is likely one of the last major ACA policy efforts of the president’s first term.
FTC Chief Gears Up for a Showdown With Private Equity
Lina Khan, chair of the FTC, says a recent lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.
Biden Administration’s Limit on Drug Industry Middlemen Backfires, Pharmacists Say
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.
US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus
The government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S. under its current approach.
Prevención del VIH: proponen que Medicare cubra PrEP para adultos mayores
Según el plan de la administración Biden, Medicare cubriría el costo total de los medicamentos de profilaxis previa a la exposición, que previenen la transmisión del VIH.
KFF Health News' 'What the Health?': For ACA Plans, It’s Time to Shop Around
It’s Obamacare open enrollment season, which means that, for people who rely on these plans for coverage, it’s time to shop around. With enhanced premium subsidies and cost-sharing assistance, consumers may find savings by switching plans. It is especially important for people who lost their coverage because of the Medicaid unwinding to investigate their options. Many qualify for assistance. Meanwhile, the countdown to Election Day is on, and Ohio’s State Issue 1 is grabbing headlines. The closely watched ballot initiative has become a testing ground for abortion-related messaging, which has been rife with misinformation. This week’s panelists are Mary Agnes Carey of KFF Health News, Jessie Hellmann of CQ Roll Call, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachana Pradhan of KFF Health News.
Biden Pick to Lead NIH Finally Has Her Day, but Still Gets Caught Up in Drug Price Debate
Monica Bertagnolli, the president’s choice to head the National Institutes of Health, appeared before a Senate committee this week. Her confirmation has been held up by Sen. Bernie Sanders (I-Vt.), who has demanded President Joe Biden work more aggressively to lower prescription drug prices.